AAAAAA
Results:
1-15
|
Results: 15
Beatrice C. Lampkin, MD awarded the American Pediatric Hematology/OncologyDistinguished Career Award
Authors:
Lukens, JN
Citation: Jn. Lukens, Beatrice C. Lampkin, MD awarded the American Pediatric Hematology/OncologyDistinguished Career Award, J PED H ONC, 23(3), 2001, pp. 146-147
Authors:
Cooper, R
Khakoo, Y
Matthay, KK
Lukens, JN
Seeger, RC
Stram, DO
Gerbing, RB
Nakagawa, A
Shimada, H
Citation: R. Cooper et al., Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: Histopathologic features - A report from the Children's Cancer Group, MED PED ONC, 36(6), 2001, pp. 623-629
Authors:
Shimada, H
Umehara, S
Monobe, Y
Hachitanda, Y
Nakagawa, A
Goto, S
Gerbing, RB
Stram, DO
Lukens, JN
Matthay, KK
Citation: H. Shimada et al., International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors - A report from the Children's Cancer Group, CANCER, 92(9), 2001, pp. 2451-2461
Authors:
Goto, S
Umehara, S
Gerbing, RB
Stram, DO
Brodeur, GM
Seeger, RC
Lukens, JN
Matthay, DK
Shimada, H
Citation: S. Goto et al., Histopathology (international neuroblastoma pathology classification) and MYCN status in patients with peripheral neuroblastic tumors - A report fromthe children's cancer group, CANCER, 92(10), 2001, pp. 2699-2708
Authors:
Lukens, JN
Johnson, FL
Lampkin, BC
Citation: Jn. Lukens et al., American Society of Pediatric Hematology/Oncology: The first 15 years, J PED H ONC, 22(4), 2000, pp. 298-302
Authors:
Maris, JM
Weiss, MJ
Guo, C
Gerbing, RB
Stram, DO
White, PS
Hogarty, MD
Sulman, EP
Thompson, PM
Lukens, JN
Matthay, KK
Seeger, RC
Brodeur, GM
Citation: Jm. Maris et al., Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: A Children's Cancer Group study, J CL ONCOL, 18(9), 2000, pp. 1888-1899
Authors:
Schmidt, ML
Lukens, JN
Seeger, RC
Brodeur, GM
Shimada, H
Gerbing, RB
Stram, DO
Perez, C
Haase, GM
Matthay, KK
Citation: Ml. Schmidt et al., Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study, J CL ONCOL, 18(6), 2000, pp. 1260-1268
Authors:
Perez, CA
Matthay, KK
Atkinson, JB
Seeger, RC
Shimada, H
Haase, GM
Stram, DO
Gerbing, RB
Lukens, JN
Citation: Ca. Perez et al., Biologic variables in the outcome of stages I and II neuroblastoma treatedwith surgery as primary therapy: A children's cancer group study, J CL ONCOL, 18(1), 2000, pp. 18-26
Authors:
Goto, H
Keshelava, N
Matthay, KK
Lukens, JN
Gerbing, RB
Stram, DO
Seeger, RC
Reynolds, CP
Citation: H. Goto et al., Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors, MED PED ONC, 35(6), 2000, pp. 619-622
Authors:
Choi, LMR
Kim, NW
Zuo, JJ
Gerbing, R
Stram, D
Lukens, JN
Matthay, KK
Seeger, RC
Reynolds, CP
Citation: Lmr. Choi et al., Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma, MED PED ONC, 35(6), 2000, pp. 647-650
Authors:
Umehara, S
Nakagawa, A
Matthay, KK
Lukens, JN
Seeger, RC
Stram, DO
Gerbing, RB
Shimada, H
Citation: S. Umehara et al., Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular- A report from the Children's Cancer Group, CANCER, 89(5), 2000, pp. 1150-1161
Authors:
Pearson, HA
Lukens, JN
Citation: Ha. Pearson et Jn. Lukens, Ferrokinetics in the syndrome of familial hypoferremic microcytic anemia with iron malabsorption, J PED H ONC, 21(5), 1999, pp. 412-417
Authors:
DuBois, SG
Kalika, Y
Lukens, JN
Brodeur, GM
Seeger, RC
Atkinson, JB
Haase, GM
Black, CT
Perez, C
Shimada, H
Gerbing, R
Stram, DO
Matthay, KK
Citation: Sg. Dubois et al., Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival, J PED H ONC, 21(3), 1999, pp. 181-189
Authors:
Lukens, JN
Citation: Jn. Lukens, Neuroblastoma in the neonate, SEM PERINAT, 23(4), 1999, pp. 263-273
Authors:
Shimada, H
Ambros, IM
Dehner, LP
Hata, J
Joshi, VV
Roald, B
Stram, DO
Gerbing, RB
Lukens, JN
Matthay, KK
Castleberry, RP
Citation: H. Shimada et al., The International Neuroblastoma Pathology classification (the Shimada system), CANCER, 86(2), 1999, pp. 364-372
Risultati:
1-15
|